TRICCAR Announces $18.5 Million Private Placement Investment

Jul 13, 2020•about 5 years ago

Amount Raised

$18 Million

Las Vegas

Description

TRICCAR, Inc. (OTC: FOSI), a bioceutical development and marketing firm, announced that it has completed an agreement for an investment of $18,594,692 via private placement in the public entity from Antonomastic Investment Holdings, Ltd., resulting in the sale of 11,621,683 shares of common stock at $1.60 per share. As part of the investment, Nairobi, Kenya based Antonomastic Investment Holdings, Ltd. will appoint an as yet to be determined member to TRICCAR's board of directors.

Company Information

Company

Triccar

Location

Las Vegas, Nevada, United States

About

TRICCAR, Inc. is a Las Vegas, Nevada-based biomedical company, creating bioceutical solutions that support the health of those suffering from the world's most common illnesses and conditions, including, obesity, hypothyroidism, calcium deficiency, pain, diabetic neuropathy, and trigeminal neuralgia. The Company competes in markets estimated at $1 trillion in annual sales for human and animal formulations. TRICCAR products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

TRICCAR Announces $18.5 Million Private Placement Investment

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information